Comprehensive Cancer Centers of Nevada
Henry Igid is a Hematologist and Medical Oncologist with experience at Comprehensive Cancer Centers of Nevada since October 2018. Prior to this, Henry completed a Fellowship in Hematology and Medical Oncology at Texas Tech University Health Sciences Center from July 2015 to June 2018. Henry also received Internship and Residency training in Internal Medicine at The University of Connecticut School of Medicine from June 2012 to June 2015. Henry began their medical journey as a Medical Student at the University of the Philippines from June 2003 to May 2010, eventually earning a Doctor of Medicine - MD degree in Medicine.
Comprehensive Cancer Centers of Nevada
Comprehensive Cancer Centers of Nevada is the award-winning multi-specialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research with treatment centers and offices throughout Southern Nevada. Comprehensive has provided oncology services to Southern Nevada residents and visitors for more than 40 years. The practice’s specialized physician and nursing staff offers sophisticated diagnostic tools, the latest advances in cancer treatment, a full range of innovative, exclusive services and research-based care in a supportive and caring environment. In order to provide patients the most progressive and effective cancer treatments, Comprehensive expanded its clinical research program by partnering with some of the world’s most recognizable research and cancer-fighting organizations. In 1995, Comprehensive physicians became part of The US Oncology Network, one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Today, Comprehensive participates in more than 170 Phase I, Phase II and Phase III clinical research studies each year, and has helped develop more than 100 FDA approved cancer therapies including approvals for Hercepin, Provenge, TECENTRIQ®, Xofigo, Keytruda and others.